Day of dialogue: Mainstreaming emergency contraception in the National Family Welfare Program by Population Council
Population Council
Knowledge Commons
Reproductive Health Social and Behavioral Science Research (SBSR)
2013
Day of dialogue: Mainstreaming emergency
contraception in the National Family Welfare
Program
Population Council
Follow this and additional works at: https://knowledgecommons.popcouncil.org/
departments_sbsr-rh
Part of the Demography, Population, and Ecology Commons, Family, Life Course, and Society
Commons, International Public Health Commons, and the Women's Health Commons
This Report is brought to you for free and open access by the Population Council.
Recommended Citation







Day of Dialogue: Mainstreaming Emergency Contraception in the National 




3rd May 2013, Mumbai, India 
 
    
Population Council in collaboration with Family Planning Association of India, hosted a Day of 
Dialogue which addressed issues related to access, availability and use of emergency 
contraception pills (ECP). Many senior medical and public health experts and pharmaceutical 
managers got together to discuss issues related to mainstreaming of the pills and action to be 
taken to ensure its availability to women who need it. Some of the key issues addressed in 
this consultation include; provider knowledge on mechanism of action (MOA) and attitudes 
towards (a) easy access to ECP and its link to pre-marital sex and promiscuity, (b) repeat use 
of ECP, and (c) lack of information about ECP among potential users. Population Council 
shared key findings of the recent study on knowledge, attitudes and opinion of gynecologists 
and pharmacists on ECP use. The one-day consultation besides presenting national and 
global issues surrounding ECP also had a panel on the role of pharmaceutical companies, 
social marketing organizations and NGOs in increasing access of the product to all women 
who need it at an affordable price and are aware of its correct use. Another panel discussed 
the role of the public sector and medical associations in mainstreaming ECP in the National 
Family Welfare Program. This report condenses the deliberations and propositions for follow 
up actions put forward at the consultation. 
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Global overview and recent progress 
Currently ECP brands are registered in 144 countries. In USA, ECPs were approved for 
prescription use in 1999. Recently, the FDA also approved ECP as an OTC for women over 
15 years. A major barrier to making access easier has been the ambiguity of MOA. Latest 
research on most commonly used Levonorgestrel ECPs, suggests that interference with 
ovulation is the primary and possibly the only mechanism of action. ECPs do not have any 
effects after fertilization or on implantation of a fertilized egg. Moreover, repeated use of ECP 
has no serious health risks (ICEC & FIGO). These recent findings have an enormous 
contribution to making ECP access easier. 
National overview: Use and knowledge of ECP is low and skewed towards urban areas 
The NFHS-3 shows high unmet need (21 percent), high unwanted pregnancy (25 percent) but 
low awareness of ECP (less than 30 percent) and use (less than 1 percent). India also has a 
high Maternal Mortality Rate of which 9 percent is due to abortion complications. Given these 
indicators, ECP was introduced in National Family Welfare Program in 2002 and made an 
OTC drug in 2005. In 2008 the Govt. of India piloted ECP introduction in the public health 
system by making CHWs the depot holder of ECP. Even though ECP is an innovative and 
unique method that gives one last chance to prevent unwanted pregnancy, the awareness 
and use of ECP remains low. India’s Essential Medicines List still does not include ECPs, nor 
does it include any contraceptives. Overall, the average level of ECP knowledge across states 
was 14 percent, but ECP knowledge varies greatly by state, with several states having levels 
lower than 5 percent and other having levels above 25 percent. Provider knowledge is also 
uneven and often low. Pharmaceutical shop audit data shows a growing demand of ECP in 
India but with a very skewed high growth in large metros and a poor growth in rural areas.  
Gynecologists’ knowledge and reservations  
Gynecologists have strong influence on policymaking and uptake among beneficiaries and 
hence have major role in mainstreaming of ECP. Council’s study examined providers’ 
(gynecologists, pharmacists and paramedics) knowledge, attitudes and practices towards 
ECP and its provision. They found that there is a lack of knowledge about the mechanism of 
action and misconceptions about side effects and opposition from some gynecologists to 
provision of ECP as an OTC and by ASHAs. Majority (95 percent) of the gynecologists 
incorrectly believed that ECP works by preventing implantation. So their knowledge of MOA is 
not up to date information. Some have the misconception that ECP could lead to abortion. 
Gynecologists also have reservations about ECP provision as prophylactic, as an OTC, by 
CHWs and without an age restriction. They believed that women who use ECP are more 
promiscuous, have premarital sex, do not use regular FP, have STDs and have risky sexual 
behavior. Most said that married women and women who have infrequent or unprotected sex 
can use ECP but fewer said unmarried adolescents can use ECP. Most were in favor of one 
time use of ECP in same menstrual cycle but there is still ambiguity to what counts as 
repeated use and its side effects. Qualitative data shows that gynecologists believe abortion 
has gone down but there is a need for a good prospective study to assess whether easy 
access to ECP will decrease unwanted pregnancies and need of abortion. In recent years, 
newspapers and magazines have published articles with negative quotes by gynecologists 
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which further vitiate the mind of the community. 
 
There is a need for an educational campaign on awareness, repeated use and its unreliability 
if used as regular FP method. FOGSI and other medical associations should remove 
misconception about MOA among its members and their reservations on OTC and provision 
by CHWs. FOGSI, through their journal and print material like a 1 page editorial article can 
take a proactive role. However, improving of gynecologists’ knowledge on MOA will not 
address their negative attitudes. We have to address the gynecologists’ fears and 
misconceptions together to address this issue. The bias is not only in gynecologists but also 
amongst policy makers. Sensitization of all stakeholders is needed to affect their biases 
against ECP users. The FOGSI theme for the year 2013 is “innovation to implementation”. 
With the Population Foundation of India, they are making a resource for all doctors who must 
know at least the basics of contraception. They feel the need to focus on limiting population 
now more than other issues. 
Users knowledge 
Evidence from DHS and gynecologists experience indicates low knowledge of ECP among 
users. During the deliberations, a top ECP selling pharmaceutical company, Piramal reported 
that their study found many sexual health myths among users like eating papayas and 
washing up after sex will prevent pregnancy. The Urban Health Initiative in Uttar Pradesh 
showed CPR increase from 46 percent to 49.8 percent but ECP impact on CPR remained low. 
Of the 17,643 women of reproductive age in 6 cities who were asked about their current use 
of FP methods, only 7 mentioned ECPs. ECPs were sometimes confused with abortion pills. 
Younger and educated women were found to be more aware of ECP. The study also showed 
that women hid ECP use. There were irregular supplies at Govt. public health post, and 
community health days were used to provide supplies. Work done by Janani and UHI 
increased sales, and private facilities availability was made more visible. Responsible and 
accurate mass media was used to improve awareness. 
The discussion emphasized that emotions of women, who are in the moment of panic after an 
act of unprotected sex, have the right to access ECP in that moment. The consultation 
suggested many ways to reach the users. The Government’s ARSH program has started 
introducing sex education at schools to inform adolescents and young women and men. 
Correct knowledge on ECP also should be introduced and educated at schools not in the 
gynecologists’ office. Counseling is a preventive approach which needs to be ensured in all 
areas of RH.  This could also be utilized as an opportunity to inform about regular methods 
(OCP, condoms, IUD). It was debated that, girls today do not go to gynecologists, only to the 
shop to get ECP if they have had sex and are at risk of unwanted pregnancy. It may not be 
possible to do a national level campaign with pharmacists, so organizations can equip 
pharmacists with basic ability to guide women on ECP usage. The leaflet accompanying the 
pill should have few simple worded lines. 
 
The Piramal sales team runs an education drive distributing leaflets for pharmacists. But the 
challenge is that the sales team members are not trained to work on knowledge and attitudes 
of the providers whom they are in contact with. Piramal records user data from emails and 
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phone calls at the customer care center about ‘i-pill’ which are responded to by group of 
psychologists from an NGO called Avishkar.  
 
There is a need for public sector engagement for awareness, ECP provision and integration in 
other RH services. The varying civil society organizations have a critical role to play to direct 
young users. Specific roles need to be identified in advocacy and service delivery processes 
where innovation and learning’s can come in. 
Pharmacists’ knowledge and attitudes  
The Council study surveyed pharmacists in UP on their (i) knowledge on the mechanism of 
action (MOA), safety and effectiveness of ECP, (ii) their attitudes to ECP, its users, concerns 
about ECP use and its repeated use. Many pharmacists felt that unmarried women can use 
ECP (62 percent). Most reported no challenges in providing ECP and did not feel the need for 
any training or material to provide ECP (80 percent). However, most of the pharmacists in 
general had negative attitudes towards ECP and its users -74 percent believed that it easy 
access is leading to premarital sex and 46 percent believed it is leading to promiscuity. They 
also supported restriction is age for providing ECP and felt that majority of their clients were 
unmarried boys and girls. Despite of that they were happy to stock ECP because of its 
growing demand and good commission that they receive per pack of ECP.  The participants 
felt that there is a need for advocacy with pharmaceutical associations to orient them on 
correct knowledge and display IEC material, address their negative attitudes towards ECP 
use, provide leaflets to clients at pharmacy and sensitize media to project ECP correctly. 
ICEC has prepared very concise brief for pharmacists and other providers’ which are open for 
sharing and could be used for this purpose.  Questions were raised on feasibility of using 
pharmacists to provide information to their clients due to lack of privacy and time. 
Panelists believed that in rural areas and smaller towns, though the pharmacists may have 
time and space for information dissemination, but high cost of ECP leading to poor demand of 
the method discourage them to invest in stocking ECP. Hesitation of woman to disclose 
unprotected sex to pharmacist of her own village/locality also could act as barrier to free 
access. HLL’s and PSI’s experience shows that social marketing firms could play significant 
role in provision of correct knowledge of ECP and increasing its demand among women in 
need but mostly avoid it as working in rural areas is challenging and has a limited profitability.  
Advertising 
The ban on ECP advertising was put in place because of aggressive advertising for brand 
promotion. Careful advertising is needed for knowledge dissemination, and non-judgmental 
portrayal of the user. Abortion pills are under the MoHFW’s ‘Schedule F’ which means they 
cannot be advertised directly or indirectly, ECPs are under ‘Schedule K’ which means they 
can be advertised even though the ban has hindered this. The ban lead to a 50 percent 
decrease in sale, also because of side effects since retailers did not know the dosage and 
timing of ECP.  
Supply 
A presentation revealed that supply of ECP to ASHA is mostly in short who are supposed to 
provide ECP at the door step of people in rural areas and could charge Rs two as service fee.   
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The AC Nielsen ORG MARG shop audit data shows that there is a big difference in sale of 
ECP in urban vs. rural areas. 68 percent of the total ECP sale is in urban areas and 32 
percent in rural, accounting for the 70 percent population. This is indicates a general lack of 
knowledge about the method and its limited supply through pharmacies.   
Mainstreaming ECP 
In the conference mainstreaming of ECP was defined as its easy accessibility at affordable 
price, with the basket of contraceptive choice. While it is emphasized that ECP is more a 
backup method in case of unprotected sex, women should be free to access and use it with 
knowledge that ECP failure rate is much higher than regular modern contraceptives. Further, it 
also includes provision of its correct knowledge and meeting the needs of all women including 
sexually active adolescents, irrespective of marital status.  Innovative ways are needed to 
educate ASHAs on the range of methods (such as by mobile phones).  For example, in a 
distance-learning course, ASHA has to pay Rs.85 and surprisingly it has a high enrollment.  
Besides public sector, NGOs and civil society organizations have equally important role in 
educating women about the correct use of ECP. They could play an active role for advocating 
mainstreaming of ECP, regular supply of the method to ASHAs and liberalization of its 
advertisement using three 3E rules of advocacy; Evidence (numbers and facts count), 
Emotion (appeal to people’s emotions and feelings), and Eminent (have an influential person 
behind your advocacy). 
 
Way Forward 
• Awareness campaign: Increasing knowledge (especially for youth) should include 
information on ECP and also on abortion pills and OCPs since there are 
misconceptions as what is to be used under what circumstances. Both women and men 
should be the target of any such efforts.  
• Supply in rural areas and advocacy for public sector: As the present commercial viability of 
ECP is limited in rural India, public sector has to ensure regular and adequate supply of 
ECP to ASHAs. Given the limitation of the supply chain of public sector, supply of 
contraception directly to ASHAs could be outsourced to a private partner and closely 
monitored, as possible alternative.  
• Removing medical barrier: Advocacy and involvement of medical association like FOGSI 
and IMA is needed to reduce the medical barriers and negative attitudes of doctors and 
pharmacists towards use of ECP and its users. Journalists, pharmaceuticals, and 
advertising companies need to be involved to disseminate responsible messages. 
Special sessions, newsletters and their journals, social media and internet can be used 
by FOGSI to sensitize doctors and provide updates on MOA.  NGOs and civil societies 
could also play an important role both as advocating agency and providers of correct 
knowledge to all stakeholders—providers, potential users and policy makers.   
• Further research: Studies on contraceptive use pattern particularly ECP among young 
unmarried and newly married couples’ decision making process, sources of information 
and their information need could help in increasing contraceptive use and appropriate 
use of ECP among young men and women. It has been stipulated that easy 
accessibility of ECP may increase risk behavior/repeat use among adolescents, which 
also needs careful examination.  
• Overall wellbeing of women: A holistic approach in needed on improving the overall 
wellbeing and quality of life of women, starting with basic healthcare and then including 
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contraception use. Counseling, IEC/BCC or advertising, need to be people centric and 
give importance to all available contraceptive methods to meet the needs of each 







Mainstreaming Emergency Contraception in the National Family Welfare Program 
May 3, 2013 
Venue: Terrace Hall, West End Hotel Mumbai, India 
09:30 am – 9: 50 am Registration 
9:50 am -10:35 am WELCOME AND INAUGURAL SESSION 
9:50 am – 10:00 am Welcome: Mr. Vishwanath Koliwad, Secretary General, FPA India  
10:00 am – 10:10 am Context and Purpose of the Meeting: Dr. M.E. Khan, Senior Associate, Population Council  
10:10 am – 10:20 am Opening  Remarks: Dr. S.K. Sikdar, Deputy Commissioner, In-charge FP, Research Studies and Standards, Ministry of Health and Family Welfare  
10:20 am – 10:35 am Inaugural Address: Sh. Jayant Kumar Banthia, Principal Secretary, Public Health Department, Govt. of Maharashtra  
10:35 am – 12:30 pm  SESSION I: Global and national overview  
 Moderators: Dr. R.P. Soonawala, Senior Gynecology Consultant  Dr. Suneeta Sharma ,Country Director, Futures Group 
10:35 am – 10:55 am 
Global perspective and recent developments on ECP in USA 
Ms. Sarah Rich, Program Officer, International Consortium for Emergency 
Contraception  
10:55 am – 11:15 am Gynecologists’ knowledge, attitudes and practices influencing access to ECP  Ms. Anvita Dixit, Assistant Program Officer, Population Council 
11:15 am – 11:35 am Experience of the Urban Health Initiative (UHI) in providing ECP Dr. Rajni Wadhwa, Technical Specialist, UHI, FHI 360 
11:35 am – 11:55 am Pharmacists’ knowledge, attitudes and practices influencing access to ECP  Ms. Isha Bhatnagar, Program Officer, Population Council 
12:15 pm – 12:30 pm Discussion  
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12:30 pm – 1:30 pm 
SESSION II: Role of pharmaceutical companies, social marketing organizations 




Dr. Daya Krishan Mangal, State Programme Coordinator, UNFPA Maharashtra 




Mr. Sachin Rajpal, General Manager Marketing, Consumer Products Division, 
Piramal Enterprises Ltd.  
Dr. Sandeep Ghiya, Freelance Consultant 
Dr. Kalpana Apte, Assistant Secretary General (Program Implementation), FPA 
India  
Mr. Naveen Kumar Bansal, General Manager Sales, Population Services 
International  
Discussion  
1:30 pm – 2:15 pm  LUNCH 
2:15 pm – 3:30 pm SESSION III: Role of public sector and medical associations in mainstreaming access to ECP 
 Moderators: Dr. Usha R. Krishna, Senior Gynecology Consultant  Dr. Rita Leavell, Chief of Party, Improving Health Behaviors Program, FHI 360 
 
Panelists:  
Dr. R. P. Soonawala, Senior Gynecology Consultant  
Dr. S.K. Sikdar, Deputy Commissioner, Research Studies and Standards, Ministry of 
Health and Family Welfare  
Dr. Hema Divakar, President, FOGSI 
Prof. Jay K. Satia, Senior Director (Academics), Public Health Foundation of India   
Discussion  
3:30 pm – 3:50 pm Concluding Remarks Dr. Kumudha Aruldas, Program Associate, Population Council  
3:50 pm – 4:00 pm Vote of thanks Ms. Bindiya Nimla, Director - Advocacy and Training, FPA India  
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Venue: Terrace Hall, West End Hotel, Mumbai, India 
S No. Name Organization Email Address  
1.  Sarah Rich International Consortium for EC srich@familycareintl.org 
2.  Bina Joshi NIRRH (ICMR) nirrhdor@yahoo.co.in 
3.  Pallavi Utagi Piramal H/C pallavi.patil@piramal.com 
4.  Amita Dham FPA India amita@fpaindia.org 
5.  Shiv Kumar ICMR Delhi shivktayal@hotmail.com 
6.  A.L. Sharda Population First alsharda2002@yahoo.com 
7.  Jay Satia PHFI jsatia@iiphg.org 
8.  Dr. Manisha Bhise FPA India manishabhise@fpaindia.org 
9.  Dr. Rita Leavell IHBP/FHI 360 rleavell@fhi360.org 
10.  Rajni Wadhwa UHI rwadhwa@uhi-india.org 
11.  Sharmistha K FHI 360 skhobragade@fhi360.org 
12.  Shrabani Sen FHI 360, Delhi ssen@fhi360.org 
13.  Chander Shekhar IIPS Mumbai buddhab@iips.net 
14.  Lysander Menezes PATH, Delhi lmenezes@path.org 
15.  Dr. Sandeep Ghiya Consultant consulting@sandeepghiya.org 
   
   
 






Name Organization Email Address  
16.  Manjula Varma DBM, FPA India mvarma@fpaindia.org 
17.  Dr. Kalpana Apte FPAI kalpanaapte@fpaindia.org 
18.  Dr. Daya Krishan Mangal UNFPA Maharashtra State Office mangal@unfpa.org 
19.  Dr Kranti Rayama FPA India kranti@fpaindia.org 
20.  Dr. Monique Kumar FPA India monique@fpaindia.org 
21.  Dr. D. S. Panwar IntraHealth International dpanwar@intrahealth.org 
22.  Naveen Bansal Population Services International nbansal@psi.org.in 
23.  Armin Neogi FPA India armin@fpaindia.org 
24.  Unnati Machchhar College of Social Work, Nirmala Niketan munnatic@gmail.com 
25.  Jameel Zamir IPPF-SAR jzamir@ippfsar.org 
26.  Priya Jha Institute for Reproductive Health, 
Georgetown University 
pjha@irh.in 
27.  Suneeta Sharma Futures Group ssharma@futuresgroup.com 
28.  Dr. Usha Krishna FPA India drushark@sify.com 
29.  Rustom Soonawala FPA India soonawalaclinic@hotmail.com 
30.  Ashwini B. Ghandhi FOGSI ashwinibgandhi@rediffmail.com 
31.  Dr. Hema Divakar FOGSI drhemadivakar@gmail.com 
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32.  Dr. Kumudha Aruldas Population Council karuldas@popcouncil.org 
33.  Anil Paul Population Council apaul@popcouncil.org 
34.  Isha Bhatnagar Population Council ibhatnagar@popcouncil.org 
35.  Anvita Dixit Population Council adixit@popcouncil.org 
36.  Dr. M.E. Khan Population Council mekhan@popcouncil.org 
37.  Seema Sharma FPA India seema@fpaindia.org 
38.  Bindiya Nimla FPA India bindiya@fpaindia.org 
39.  Vishwanath Koliwad FPA India vishwanath@fpaindia.org 
    
    
    
    
    
    
    
 
      
 
 
 
